4Platt JL, Burke BA, Fish AJ, et al. Systemic lupus erythematosus in the first two decades of life [ J ]. Am J Kidney Dis, 1982,2 ( suppl 1 ) :212 - 222.
5Tan EM, Cohen AS, Fries JF,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus [ J ]. Arthritis Rheum, 1982, 25(11) :1271 - 1277.
6Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[ J]. Arthritis Rheum, 1997,40 (9) : 1725.
8Churg J, Sobin LH. Renal disease : Classification and atlas of glomerular disease [ M ]. Tokyo : lgaku - Shoin, 1952.
9Weening JJ,D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited[ J]. J Am Soc Nephrol,2004,15(2) :241 -250.
10Gourley MF, Austin HA,3rd, Scott D,et al. Methylprednisolone and cyclophosphamide, alone or in combination,in patients with lupus nephritis. A randomized, controlled trial [ J ]. Ann Intern Med, 1996,125 ( 7 ) : 5495 - 5457.
2Andersson M, Aronsson P, Giglio D, et al.Pharmacological modulation of the micturition pattern in normal and cyclophosphamide pre-treated conscious rats[J].Auton-Neurosci, 2011,159 ( 1-2 ) : 77-83.
3Lyons L, Elbehagy M, Bennett G, et al.The effects of cyclophosphamide on hippocampal cell proliferation and spatial working memory in rat[J].PLoS- One,2011,6 (6): e21445.
4Tam CS, Seymour JF.Fludarahine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma : high efficacy may come at a cost?[J].Leuk-Lymphoma, 2011,52 ( 5 ): 729-731.
5Taheri S, Beiraghdar F.Lupus nephritis in Iranian children: a review of 60 patients[J].Ren-Fail, 2011,33 ( 5 ) : 499-505.
6Austin III H A, Illei G G, Balow J E.Lupus membranous nephropathy[J].Lupus Nephritis, 2011, 24(3): 169-197.
7Hahn B H, McMahon M A, Wilkinson A, et al.American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis[J].Arthritis Care Res, 2012, 64(6): 797-808.
8Rovin B H, Furie R, Latinis K, et al.Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study[J].Arthritis Rheum, 2012, 64(4): 1215-1226.
9Arends S, Grootscholten C, Derksen R H, et al.Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis[J].Ann Rheum Dis, 2012, 71(6): 966-973.
10Dooley M A, Jayne D, Ginzler E M, et al.Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis[J].N Engl J Med, 2011, 365(20): 1886-1895.
